Angélique BETTON

En résumé

Entreprises

• Pierre Fabre - International Clinical Study Coordinator

  Castres 2004 - maintenant Phase III study in breast cancer for registration in China (since 2013)
  - Set up activity in China with 1 CRO
  - Responsible for SAEs (analysis, tracking, periodic review)
  - Responsible for SOPs implementation
  - Responsible for study deviation (periodic review, follow up of CAPA implementation)
  - Responsible for oversight of the CTMS
  - Involved in drafting study documents
  
  
  Phase III study in breast cancer for registration in Europe (since 2006)
  1000 patients all over the world,
  - Responsible for study activities conducted in 3 countries Pierre Fabre affiliates (France, Belgium, Portugal and 1 country handled by a CRO (India)
  - Presentation and organization of study meetings with investigators and CRA
  - Follow up of all the monitoring activities
  - Development of tools to track IPs
  - Involved in drafting SOPs (IP, SAE, monitoring, study deviations)
  - Validation of clinical data (446 patients)
  - Closing out activities
  
  Phase III study in lung cancer (since 2004)
  - Writing 170 SAE narratives
  - Closing out activities

• Pierre Fabre - Clinical Research Associate

  Castres 2001 - 2004 - Therapeutic area: prostate cancer, lung cancer, mesothelioma...
  - Phase: I, II and III

• Pierre Fabre - International Clinical Study Coordinator

  Castres 2001 - 2001 - Therapeutic area: lung cancer
  - Phase : II

• AstraZeneca - Clinical Research Associate

  Rueil-Malmaison 2000 - 2001 - Therapeutic area: lung cancer
  - Phase: II and III

• Pierre Fabre - Clinical Research Associate Trainee

  Castres 2000 - 2000 - Therapeutic area: prostate cancer, lung cancer and myeloma
  - Phase: II and III

Formations

Réseau

• Agnès DHERMAIN - MEURISSET

• Cécile COUSY

• Clothilde MANZANO

• Debborah BAMOUH

• Maria BARBIER

• Marie-Gabrielle COMMENIL

• Mougenot RENAUD

• Stanislas KRASENSKY